Author Manuscript Published OnlineFirst on July 17, 2018; DOI: 10.1158/2326-6066.CIR-18-0037 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Response to Immune Checkpoint Inhibition in Two Patients with Alveolar Soft Part Sarcoma Authors: Jeremy Lewin, 1 Scott Davidson, 2,3 Nathaniel D. Anderson, 3 Beatrice Y. Lau, 4 Jacalyn Kelly, 2,5,6 Uri Tabori, 2,5,7 Samer Salah, 1 Marcus O. Butler, 1 Kyaw L. Aung, 1 Adam Shlien, 2,3 Brendan C. Dickson, 4 Albiruni R. Abdul Razak 1 1 Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada 2 Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Canada 3 Department of Paediatric Laboratory Medicine, The Hospital for Sick Children, Toronto, Canada 4 Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Canada 5 The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, Ontario, Canada. 6 Department of Medical Biophysics, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada. 7 Division of Hematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada Downloaded from cancerimmunolres.aacrjournals.org on July 19, 2018. © 2018 American Association for Cancer Research.